Value of dobutamine echocardiography for the assessment of myocardial viability for revascularization

Congestive Heart Failure

Volumn 7, Issue 1, 2001, Pages 30-36

  Senior, R ^a   Lahiri, A ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTION; PROGNOSIS; RADIODIAGNOSIS; REVIEW; SAFETY; SURVIVAL; VALIDATION PROCESS;

EID: 0035125504     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2001.00865.x     Document Type: Review

References (35)

1. An overview of contemporary etiologies of congestive heart failure
2. Results of coronary artery surgery in patients with poor left ventricular function (CASS)
3. Surgical survival benefit for coronary disease in patients with left ventricular dysfunction
4. Revascularisation for chronic heart failure: A valid option?
5. Patient extrasystolic potentiation of ischaemic myocardium by atrial stimulation
6. A perspective of the three multicentre randomised clinical trials of coronary bypass surgery for chronic stable angina
7. Ischaemic cardiomypoarthy: Criteria for myocardial revascularisation and cardiac transplantation
8. Severe ischaemic left ventricular failure: Coronary operation or heart transplantation?
9. Coronary artery bypass in patients with severely depressed ventricular function
10. Improved outcome after coronary bypass surgery in patients with ischaemic cardiomypathy and residual myocardial viability
11. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
12. Myocardial viability on echocardiography predicts long term survival after revascularisation in patients with ischaemic congestive heart failure
13. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular dysfunction
14. Mechanisms of chronic regional post-ischaemic dysfunction in humans: New insights from the study of noninfarcred collateral-dependent myocardium
15. A canine model of chronic ischaemic cardiomyopathy: Characterisation of regional flow function relations
16. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium
17. Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging
18. Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischaemia in dogs
19. Recruitment of an inotropic reserve in moderately ischaemic myocardium at the expense of metabolic recovery: A model of short term hibernation
20. Functional and structural alterations with 24-hour myocardial hibernation and recovery after perfusion: A pig model of myocardial hibernation
21. Dobutamine positron emission tomography: Absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease
22. Development of short-term myocardial hibernation: Its limitation by the severity of ischaemia and inotropic stimulation
23. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease
24. Pathophysiology of myocardial hibernation: Implications for the use of dobutamine echocardiography to identify myocardial viability
25. Accuracy of currently available techniques for prediction of functional recovery after revascularisation in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
26. Direct measurement inner and outer wall thickening dynamics with epicardial echocardiography
27. Enhanced detection of myocardial ischaemia by stress dobutamine echocardiography utilising the "biphasic" response of wall thickening during low and high dose dobutamine infusion
28. Dobutamine echocardiography in myocardial hibernation: Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty
29. Dobutamine stress echocardio-graphy identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularisation
30. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularisation in patients with coronary artery disease
31. Dobutamine echocardiography and thallium 201 imaging predict functional improvement after revascularisation in severe ischaemic left ventricular dysfunction
32. Prediction of improvement of regional left ventricular function after surgical revascularisation: A comparison of low dose dobutamine echocardiography with 201T1 single photon emission computed tomography
33. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts
34. Prediction of recovery of myocardial dysfunction following revascularisation: Comparison of F18 fluorodeoxyglucose/thallium-201 single photon emission computed tomography, thallium-201 stress-reinjection single photon emission computed tomography and dobutamine echocardiography
35. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischaemic dysfunction